Infectious Diseases (except HIV/AIDS)

  1. Screening for SARS-CoV-2 by RT-PCR: Saliva or nasopharyngeal swab? Rapid review and meta-analysis

    1. Nusaïbah Ibrahimi
    2. Agnès Delaunay-Moisan
    3. Catherine Hill
    4. Gwénaël Le Teuff
    5. Jean-François Rupprecht
    6. Jean-Yves Thuret
    7. Dan Chaltiel
    8. Marie-Claude Potier

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Response to Whole-Lung Low-Dose Radiation Therapy (LD-RT) Predicts Freedom from Intubation in Patients Receiving Dexamethasone and/or Remdesevir for COVID-19-Related Acute Respiratory Distress Syndrome (ARDS)

    1. Clayton B. Hess
    2. Tony Y. Eng
    3. Tahseen H. Nasti
    4. Vishal R. Dhere
    5. Troy J. Kleber
    6. Jeffrey M. Switchenko
    7. Brent D. Weinberg
    8. Nadine Rouphael
    9. Sibo Tian
    10. Soumon Rudra
    11. Luisa S. Taverna
    12. Alvaro Perez
    13. Rafi Ahmed
    14. Mohammad K. Khan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya

    1. Ifedayo M. O. Adetifa
    2. Sophie Uyoga
    3. John N. Gitonga
    4. Daisy Mugo
    5. Mark Otiende
    6. James Nyagwange
    7. Henry K. Karanja
    8. James Tuju
    9. Perpetual Wanjiku
    10. Rashid Aman
    11. Mercy Mwangangi
    12. Patrick Amoth
    13. Kadondi Kasera
    14. Wangari Ng’ang’a
    15. Charles Rombo
    16. Christine Yegon
    17. Khamisi Kithi
    18. Elizabeth Odhiambo
    19. Thomas Rotich
    20. Irene Orgut
    21. Sammy Kihara
    22. Christian Bottomley
    23. Eunice W. Kagucia
    24. Katherine E. Gallagher
    25. Anthony Etyang
    26. Shirine Voller
    27. Teresa Lambe
    28. Daniel Wright
    29. Edwine Barasa
    30. Benjamin Tsofa
    31. Philip Bejon
    32. Lynette I. Ochola-Oyier
    33. Ambrose Agweyu
    34. J. Anthony G. Scott
    35. George M. Warimwe

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. A longitudinal seroconversion panel shows anti-SARS-CoV-2 antibody levels up to 6.5 months after vaccination with mRNA-1273 (Moderna)

    1. Francisco Belda
    2. Oscar Mora
    3. Rebecca Christie
    4. Michael Crowley

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Is Mandatory Vaccination in Population over 60 Adequate to Control the COVID-19 Pandemic in E.U.?

    1. Nikolaos P. Rachaniotis
    2. Thomas K. Dasaklis
    3. Filippos Fotopoulos
    4. Michalis Chouzouris
    5. Vana Sypsa
    6. Antigone Lyberaki
    7. Platon Tinios

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Mapping the global landscape of chikungunya rapid diagnostic tests: A scoping review

    1. José Moreira
    2. Patrícia Brasil
    3. Sabine Dittrich
    4. André M. Siqueira

    Reviewed by PeerRef

    3 evaluationsAppears in 1 listLatest version Latest activity

  7. Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection

    1. Hans P Verkerke
    2. Gregory L Damhorst
    3. Daniel S Graciaa
    4. Kaleb McLendon
    5. William O’Sick
    6. Chad Robichaux
    7. Narayanaiah Cheedarla
    8. Sindhu Potlapalli
    9. Shang-Chuen Wu
    10. Kristin R V Harrington
    11. Andrew Webster
    12. Colleen Kraft
    13. Christina A Rostad
    14. Jesse J Waggoner
    15. Neel R Gandhi
    16. Jeannette Guarner
    17. Sara C Auld
    18. Andrew Neish
    19. John D Roback
    20. Wilbur A Lam
    21. N Sarita Shah
    22. Sean R Stowell

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco

    1. Jihane Belayachi
    2. Majdouline Obtel
    3. Rachid Razine
    4. Redouane Abouqal

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination

    1. Jinyi Tang
    2. Cong Zeng
    3. Thomas M. Cox
    4. Chaofan Li
    5. Young Min Son
    6. In Su Cheon
    7. Yue Wu
    8. Supriya Behl
    9. Justin J. Taylor
    10. Rana Chakaraborty
    11. Aaron J. Johnson
    12. Dante N. Shiavo
    13. James P. Utz
    14. Janani S. Reisenauer
    15. David E. Midthun
    16. John J. Mullon
    17. Eric S. Edell
    18. Mohamad G. Alameh
    19. Larry Borish
    20. William G. Teague
    21. Mark H. Kaplan
    22. Drew Weissman
    23. Ryan Kern
    24. Haitao Hu
    25. Robert Vassallo
    26. Shan-Lu Liu
    27. Jie Sun

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Impact of voluntary risk-mitigation behaviour on transmission of the Omicron SARS-CoV-2 variant in England

    1. Ellen Brooks-Pollock
    2. Kate Northstone
    3. Lorenzo Pellis
    4. Francesca Scarabel
    5. Amy Thomas
    6. Emily Nixon
    7. David A. Matthews
    8. Vicky Bowyer
    9. Maria Paz Garcia
    10. Claire J. Steves
    11. Nicholas J. Timpson
    12. Leon Danon

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 215 of 716 Next